EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

15 | GDF5 therapeutic potential for Duchenne muscular dystrophy

Interuniversity Institute of Myology

European Journal of Translational Myology · 03.04.2026 · 36 (s2)

DOI: 10.4081/ejtm.2026.15463 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Translational Myology, online erschienen am 03.04.2026. Verfasst von Interuniversity Institute of Myology. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Duchenne muscular dystrophy (DMD) is a fatal disease characterized by the absence of dystrophin, leading to degeneration of the entire musculature. With the aim of improving muscle pathophysiology and gene therapy for DMD, we investigated the potential of growth differentiation factor 5 (GDF5) in the DMD mdx mouse model. We showed that muscle overexpression of GDF5 improved its histology, reduced inflammation, modulated regeneration and induced the appearance of de novo fibers. We demonstrated that muscle satellite cells (MuSCs) are targeted by GDF5 which enhanced their proliferation and slowed down their fusion. Next, we combined GDF5 overexpression with AAV-microdystrophin, the key gene therapy treatment for DMD, and showed an increased number of microdystrophinpositive myofibers compared with gene therapy alone. Overall, we decipher here the role of GDF5 in improving DMD pathophysiology and provide a first proof of concept of a synergistic effect of the combination of AAV-GDF5 and AAV-microdystrophin.

Zitieren

APA

Myology, I. I. O. (2026). 15 | GDF5 therapeutic potential for Duchenne muscular dystrophy. European Journal of Translational Myology, 36(s2). https://doi.org/10.4081/ejtm.2026.15463

Vancouver

Myology IIO. 15 | GDF5 therapeutic potential for Duchenne muscular dystrophy. European Journal of Translational Myology. 2026;36(s2). doi:10.4081/ejtm.2026.15463

BibTeX
@article{Myology2026,
  author = {Myology, Interuniversity Institute of},
  title = {15 | GDF5 therapeutic potential for Duchenne muscular dystrophy},
  journal = {European Journal of Translational Myology},
  year = {2026},
  volume = {36},
  number = {s2},
  doi = {10.4081/ejtm.2026.15463}
}
Kostenlos starten →